A study of cytological pattern of cervical papanicolaou smears in western Rajasthan, India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20163009Keywords:
Cervical pattern, Bethesda system, Pap smearAbstract
Background: Cervical cancer is one of the most common cancers of Indian females. Western Rajasthan differs a lot from rest of India in respect of geographical conditions, environment, culture, population density etc. and it also has relatively lower literacy rate which is one of the risk factor for many diseases. The objective of this study was to estimate the prevalence of cervical cytological pattern in females of western Rajasthan by using conventional Papanicolaou (Pap) smears for the screening of inflammatory, premalignant and malignant lesions of the cervix.
Methods: This cross sectional study was conducted at tertiary care institute of western Rajasthan for 1.5 year duration, on 1768 females who were screened by Pap smear examination. After staining with conventional Papanicolaou technique, all smears were classified as per Bethesda nomenclature.
Results: Out of 1768 smears 1039 (58.7%) were abnormal Pap smears, 445 (25.1%) were normal Pap smears while 284 (16.1%) smears had inadequate sample material to be examined. Out of 1039 abnormal smears, 956 (92.01%) smears reported to have inflammatory/reactive changes whereas 26 (2.50%) had atrophic changes in Pap smear and abnormality in epithelial cell was reported in 57(5.49%) smears.
Conclusions: Pap smear examination is an effective screening procedure to detect cervical cytological abnormalities. Routine cytological screening by Pap smear should be offered to all women above 19 years or within 3 years of sexual activity. It is recommended to improve the awareness about the disease amongst females and skills of health care personal about proper preparation of Pap smear.Metrics
References
Juneja A, Sehgal A, Sharma S, Pandey A. Cervical cancer screening in India: Strategies revisited. Indian J Med Sci. 2007;61:34-47.
NCMH background papers-burden of disease in India. New Delhi: Ministry of Health and Family Welfare, Government of India; 2005.
Desai M. An assessment of community based cancer screening program among Indian Women Using the Anganwadi Workers. Obstet Gynecol Ind. 2004:54:483-7.
Adhikary AK, Banik U, Numaga J, E Suzuki, T Inada, N Okabe, et al. Heterogeneity of the fiber sequence in subgenus C adenovirus. J Clin Pathol. 2004;57:612-7.
Toews HA. The abnormal pap smear: a rationale for follow up. Can Fam Physician. 1983;29:759-62.
Guidelines for cervical cancer screening programme. Government of India-World Health Organization Collaborative Programme, 2006.
Murthy NS, Chaudhary K, Saxena S. Trends in cervical cancer incidence: indian scenario. Eur J Cancer Prev. 2005;14:513-8.
Papanicolaou GN, Traut HF.The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol. 1941;42:193-206.
Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on a workshop of the UICC project on Evaluation of Screening for Cancer. Int J Cancer. 1990;46:761-9.
Walton RJ. The task force on cervical cancer screening programs. Can Med Assoc J. 1976;114:981.
Hakama M, Rasanen VU. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol. 1976;103:512-7.
Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the nordic countries: Association with organized screening programs. Lancet. 1987;1:1247-9.
Anderson GH, Boyes DA, Benedet JL, Le Riche JC, Matisic JP, Suen KC, et al. Organization and results of the cervical cytology screening program in British Columbia. 1955-85. Br Med J (Clin Res Ed). 1988 296:975
Padubidri V, Daftary SN. Gynecological diagnosis. In: Howkins and Bourne Shaw’s textbook of Gynecology. 13th ed. Noida: Elsevier India Private Ltd; 2004:77.
Zamani N. Management of abnormal cervical cytology. J Coll Physc Surg Pak. 1994;4:28-9.
Yousaf A, Yousaf NW. Review of cervical intra epithelial neoplastic (CIN) latest concepts of screening and management protocol. Pak J Obstet Gynaecol. 1992;5:23-5.
Singh P, Ilancheran A. The pap or cervical smear and the role of colposcopy in screening for carcinoma of the cervix. Singapore Med J. 1989;30:302-5.
Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M. Forum group members; Bethesda 2001 Workshop. The 2001 bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-9.
Dinshaw KA, Shastri SS. Screening for cervical cancer in India. Natl Med J India. 2001;14(1):1.
Juneja A, Sehgal A, Sharma S, Pandey A. Cervical cancer screening in India: Strategies revisited. Indian J Med Sci. 2007;61(1):34-47.
Dutta PK, Upadhyay A, Dutta M, Ganguly SS. A case control study of cancer cervix patients attending Command Hospital, Pune. Ind J Cancer. 1990;27:101-8.
Caplash N, SobtiC. Epidemiology of cervical cancer-a case control study on north indian population. Indian J Cancer. 1999;36:179-85.
Prabhakar AK, Menon JR. Age at marriage and cervical cancer incidence. Indian J Cancer 1995;2:63-8.
Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. J Cytol. 2012;29:45-7.
Elhakeem HA, Al-Ghamdi AS, Al-Maghrabi JA. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia. Saudi Med J. 2005;26:588-92.
Shekhar H, Pancharia A, Chauhan S, Kaur A, Chauhan S. Cytological pattern of cervical papanicolaou smear in rajasthan. Int J Dent Med Res. 2014:1-7.
Patel MM, Pandya AN, Modi J. Cervical Pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. Natl J Com Med. 2011;1:49-51.
Gupta S, Sodhani P, Halder K, Chachra KL, Singh V, Sehgal A. Age trends in pre-cancerous and cancerous lesions of the uterine cervix in a cytology screening programme: what should be the target age group for a major thrust of screening in resource-limited settings? Cytopathology. 2008;19(2):106-10.
Misra JS, Singh U. Results of long term hospital based cytological screening in asymptomatic women. Diagn Cytopathol. 2006;34:184-7.
Patel TS, Bhullar C, Bansal R, Patel SM. Interpreting epithelial cell abnormalities detected during cervical smear screening: a cytohistologic approach. Eur J Gynaecol Oncol. 2004;25:725-8.
Misra JS, Srivastava S, Singh U, Srivastava AN. Risk-factors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Indian J Cancer. 2009;46:155-9.
Mulay K, Swain M, Patra S, Gowrishankar S. A comparative study of cervical smears in an urban hospital in India and a population based screening program in Mauritius. Indian J Pathol Microbiol. 2009;52:34-7.
Gupta S, Sodhani P, Halder K, Chachra KL, Sardana S, Singh V, et al. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: implications for resource limited settings. Eur J Obstet Gynecol Reprod Biol. 2007;134:238-42.